Select Bibliography

Filter by any of these (after searching):

There are 68 items

A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: an Alliance Foundation trial (AFT-19)

Aggarwal, Rahul , Eggener, Scott , Chen, Ronald , Heller, Glenn ... - ASCO - J Clin Oncol - 2018

Abstract - No-Endpoint - Trial-Description-Only - GU - AFT-19

Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (MIBC) (AMBASSADOR) vs Observation

Apolo, Andrea , Rosenberg, Jonathan , Morris, Michael ... - ASCO GU - J Clin Oncol - 2019

Abstract - No-Endpoint - Trial-Description-Only - GU - A031501

Cancer and Leukemia Group B studies of recombinant Interleukin-2 maintenance therapy in acute myeloid leukemia

Baer, M. R. , Kolitz, J. E. , George, S. L. , Caligiuri, M. A. ... - - Ann Hematol - 2008

Abstract - No-Endpoint - Comprehensive - Leukemia - CALGB-19808

New strategies to improve drug development in carcinoid tumors (Alliance A021202)

Bergsland, Emily K. , Mahoney, Michelle R. , Asmis, Timothy R. ... - NETRF - - 2019

Abstract - No-Endpoint - Trial-Description-Only - GI - A021202

Demonstrating the value of coincidence analysis for identifying successful implementation strategies

Birken, Sarah A. , Hwang, Soohyun , Viera, Laura , Haines, Emily ... - SIRC - - 2019

Abstract - No-Endpoint - Primary - ACS CCDRC - A23_Pilot2

Validating results from coincidence analysis (a variant of qualitative comparative analysis) using multiple models from diverse stakeholders

Birken, Sarah A. , Hwang, Soohyun , Whitaker, Rebecca , James, Ted A. ... - DIH - - 2019

Abstract - No-Endpoint - Primary - ACS CCDRC - A23_Pilot2

Challenges for conducting clinical trials evaluating maintenance chemotherapy in acute myeloid leukemia (AML): a Cancer and Leukemia Group B (CALGB) study

Blum, W. , Donohue, K. , Marcucci, G. , Deangelo, D. J. , Uy, G. L. ... - ASH - Blood - 2010

Abstract - No-Endpoint - Comprehensive - Leukemia - CALGB-10503

Development of Clinical Precision Medicine Approaches in Meningiomas: Alliance A071401.

Brastianos, Priscilla , Shi, Qian , Santagata, Sandro ... - SNOM - - 2016

Abstract - No-Endpoint - Trial-Description-Only - Neuro-Onc - A071401

Teaching Health-Care Providers to Query Patients With Cancer About Sexual and Gender Minority (SGM) Status and Sexual Health

Cathcart-Rake, Elizabeth J. , Breitkopf, Carmen Radecki ... - - Am J Hosp Palliat Care - 2019

Manuscript - No-Endpoint - Trial-Description-Only - Disparities - Pilot

How (and Why) to Ask the Older Cancer Patient about Sexual Health and Sexual Minority Status

Cathcart-Rake, Elizabeth , O’Connor, Jennifer M. , Jacobson, Alison ... - - J Geriatr Oncol - 2019

Manuscript - No-Endpoint - Other - Disparities - Pilot

Querying Cancer Patients About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Healthcare Providers

Cathcart-Rake, Elizabeth , O’Connor, Jennifer M. ... - - Am J Hosp Palliat Care - 2020

Manuscript - No-Endpoint - Primary - Disparities - Pilot

Innovative estimation of survival using log-normal survival modelling on ACCENT database

Chapman, J W , O'Callaghan, C J , Hu, N , Ding, K , Yothers, G A ... - - Br. J. Cancer - 2013

Manuscript - No-Endpoint - Primary - GI - N0441

Methodological Considerations in the Design and Implementation of Clinical Trials

Cirrincione, Constance T. , Lavoie Smith, Ellen M. ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - Pilot

Hypothetical double-consent design intervention

Demmy, T. L. , Kohman, L. J. ... - CTAS - - 2010

Abstract - No-Endpoint - Primary - Respiratory - CALGB-30102 , CALGB-9334

Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group

Diehl, Kathleen M. , Green, Erin M. , Weinberg, Armin ... - - Ann. Surg. Oncol. - 2011

Manuscript - No-Endpoint - Meta-Analysis - Disparities - Comprehensive

Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Dueck, A. C. , Mendoza, T. R. , Mitchell, S. A. , Reeve, B. B. ... - - J. Clin. Oncol. - 2012

Abstract - No-Endpoint - Primary - Health Outcome - Comprehensive

Attitudes of Clinicians about Screening Head and Neck Cancer Survivors for Lung Cancer Using Low-Dose Computed Tomography

Dukes, Kimberly , Seaman, Aaron T. , Hoffman, Richard M. ... - - Ann. Otol. Rhinol. Laryngol. - 2020

Manuscript - No-Endpoint - Primary - Prevention - Pilot

Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

Döhner, Konstanze , Thiede, Christian , Jahn, Nikolaus ... - - Blood - 2020

Manuscript - No-Endpoint - Primary - Leuk Corr Sci - CALGB-10603

American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: A randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non–small cell lung cancer

Fernando, Hiran C. ... - - J. Thorac. Cardiovasc. Surg. - 2012

Manuscript - No-Endpoint - Trial-Description-Only - Respiratory - ACOSOG-Z4099

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early Stage Non–Small Cell Lung Cancer

Govindan, Ramaswamy , Mandrekar, Sumithra J. , Gerber, David E. ... - - Clin. Cancer Res. - 2015

Manuscript - No-Endpoint - Trial-Description-Only - Respiratory - A151216

Optimal Two-Stage Dynamic Treatment Regimes from a Classification Perspective with Censored Survival Data

Hager, Rebecca , Tsiatis, Anastasios A. ... - - Biometrics - 2018

Manuscript - No-Endpoint - Comprehensive - Leukemia - C9710

N0733: Phase II trial of capecitabine and lapatinib +/- cixutumumab in HER2 positive breast cancer

Haluska, P. , Reinholz, M. M. , Dueck, A. C. , Linden, H. M. ... - - J. Clin. Oncol. - 2010

Abstract - No-Endpoint - Trial-Description-Only - Breast - N0733

Public Health and Cooperative Group Partnership: A Colorectal Cancer Educational Intervention for Breast Cancer Survivors

Homan ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Comprehensive - Onc Nursing - A21_011

A phase II study evaluating the role of sentinel lymph node surgery and axillary lymph node dissection following preoperative chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis: ACOSOG Z1071

Hunt, K. , Le-Petross, H. T. , Suman, V. , Haffty, B. G. ... - - J. Clin. Oncol. - 2010

Abstract - No-Endpoint - Trial-Description-Only - Breast - ACOSOG-Z1071

The role of patient advocates in clinical trials: Perspectives from investigators and advocates in the Cancer and Leukemia Group B (CALGB)

Katz, M. L. , Archer, L. E. , Peppercorn, J. M. , Kereakoglow, S. ... - - J. Clin. Oncol. - 2010

Abstract - No-Endpoint - Other - Patient Adv - No Study Assigned

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Katz, Matthew H. G. , Ou, Fang-Shu , Herman, Joseph M. ... - - BMC Cancer - 2017

Manuscript - No-Endpoint - Trial-Description-Only - GI - A021501

Borderline resectable pancreatic cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

Katz, Matthew HG , Marsh, Robert , Herman, Joseph M. , Shi, Qian ... - - Ann. Surg. Oncol. - 2013

Manuscript - No-Endpoint - Comprehensive - GI - A021101

Alliance for clinical trials in oncology trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Katz, Matthew , Herman, Joseph M. , Ou, Fang-Shu , Marsh, Robert ... - ASCO - J. Clin. Oncol. - 2017

Abstract - No-Endpoint - Trial-Description-Only - GI - A021501

Nursing contributions in Community Clinical Oncology Research Programs.

Klinger, Kathy , Figueras, Cesar , Beney, Kathleen M , Armer, Jane M ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Comprehensive - Onc Nursing - No Study Assigned

Nursing's presence in the changing cooperative group setting.

Kottschade, Lisa A , Bell, Jennifer , Klinger, Kathy ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Comprehensive - Onc Nursing - No Study Assigned

Application of multi-state models in cancer clinical trials

Le-Rademacher, Jennifer G , Peterson, Ryan A , Therneau, Terry M ... - - Clin Trials - 2018

Manuscript - No-Endpoint - Other - Leukemia - A151732 , CALGB-10603

Alliance A051202: A Phase I Trial of Lenalidomide, Rituximab and GS-1101 (Idelalisib) in recurrent follicular lymphoma

Leonard, John P. , Jung, Sin-ho ... - ICML - Hematol Oncol - 2013

Abstract - No-Endpoint - Trial-Description-Only - Lymphoma - A051202

The nurse liaison role in the cooperative group setting.

Levy, Sharon , Klinger, Kathy , Galinsky, Ilene , DeKrey, Wanda ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Comprehensive - Onc Nursing - No Study Assigned

The Breast Cancer Weight Loss (BWEL) Trial: Randomized Phase III Trial Evaluating The Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer (Alliance A011401)

Ligibel, Jennifer A. , Barry, William T. , Alfano, Catherine ... - ASCO - J Clin Oncol - 2018

Abstract - No-Endpoint - Trial-Description-Only - Breast - A011401

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

Ligibel, Jennifer A. , Barry, William T. , Alfano, Catherine ... - - NPJ Breast Cancer - 2017

Manuscript - No-Endpoint - Trial-Description-Only - Breast - A011401

A randomized phase II study of anti-PD-1 antibody [MK-3475 (pembrolizumab)] alone versus anti-PD1 antibody plus stereotactic body radiation therapy in advanced Merkel cell carcinoma (Alliance A091605)

Luke, Jason , Chmura, Steven , Salama, Joseph , Al-Hallaq, Hania ... - ASCO - J Clin Oncol - 2018

Abstract - No-Endpoint - Trial-Description-Only - Experimental - A091605

Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study

Ma, Cynthia X. , Suman, Vera , Leitch, A. Marilyn , Sanati, Souzan ... - SABCS - Cancer Res. - 2015

Abstract - No-Endpoint - Trial-Description-Only - Breast - A011106

Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples

Mahoney, D. W. , Therneau, T. M. , Anderson, S. K. , Jen, J. ... - - BMC Res Notes - 2013

Manuscript - No-Endpoint - Primary - PPP - N9831

Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)

Major-Elechi, Brittny T. , Novotny, Paul J. , Singh, Jasvinder A. ... - - Int J Stat Med Res - 2018

Manuscript - No-Endpoint - Other - Health Outcome - NCCTG-89-20-52

Impact of disease progression (DP) date determination method on post progression survival (PPS) and DP metrics in advanced lung cancer

Mandrekar, Sumithra J. , Foster, Nathan R. , Qi, Yingwei ... - ASCO - J. Clin. Oncol. - 2012

Abstract - No-Endpoint - Comprehensive - Respiratory - N0424

How Much Missing Data is Too Much? Monte Carlo Simulations to Develop SISAQOL Guidelines for Missing Data Handling.

Mazza, Gina L. , Coens, Corneel , Pe, Madeline , Dorme, Lien ... - ISOQOL - Qual Life Res - 2018

Abstract - No-Endpoint - Other - Health Outcome - N07C2

Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: The Cancer and Leukemia Group B experience

Mrózek, Krzysztof , Carroll, Andrew J. , Maharry, Kati ... - - Int. J. Oncol. - 2008

Manuscript - No-Endpoint - Comprehensive - Leuk Corr Sci - CALGB-8461

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

Mrózek, Krzysztof , Marcucci, Guido , Paschka, Peter ... - - Blood - 2007

Manuscript - No-Endpoint - Other - Leuk Corr Sci - No Study Assigned

Milestone prediction for time-to-event endpoint monitoring in clinical trials

Ou, Fang-Shu , Heller, Martin ... - - Pharm Stat - 2019

Manuscript - No-Endpoint - Other - GI - A151730

The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD

Pacyna, Joel E. , Kim, Simon , Yost, Kathleen , Sedlacek, Hillary ... - - BMC Cancer - 2018

Manuscript - No-Endpoint - Trial-Description-Only - ACS CCDRC - A191402CD

Lessons learned from implementing the first Alliance NCORP Research Base Cancer Care Delivery Research (CCDR) trial A191402CD

Pacyna, Joel E. , Sloan, Jeff , Kim, Simon , Sedlacek, Hillary ... - ASCO QCS - J Clin Oncol - 2018

Abstract - No-Endpoint - Trial-Description-Only - Disparities - A191402CD

Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance)

Pang, Herbert , Yan, Kang , Kratzke, Robert , Stinchcombe, Thomas ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint - Meta-Analysis - Respiratory - CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733

A Randomized Trial of Diet in Men with Early Stage Prostate Cancer on Active Surveillance: Rationale and Design of the Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance])

Parsons, J. Kellogg , Pierce, John P. , Mohler, James ... - - Contemp Clin Trials - 2014

Manuscript - No-Endpoint - Trial-Description-Only - Prevention - CALGB-70807

Improving standards of patient reported outcomes analysis: developing a consensus taxonomy of key research objectives – a SISAQOL initiative

Pe, Madeline , Dorme, Lien , Coens, Corneel , Basch, Ethan ... - ISOQOL - Qual Life Res - 2018

Abstract - No-Endpoint - Other - Health Outcome - No Study Assigned

Ethics of Mandatory Research Biopsy for Correlative End Points Within Clinical Trials in Oncology

Peppercorn, Jeffrey , Shapira, Iuliana , Collyar, Deborah ... - - J. Clin. Oncol - 2010

Manuscript - No-Endpoint - Comprehensive - Ethics - No Study Assigned

Tobacco Assessment in Completed Lung Cancer Treatment Trials

Peters, Erica N. , Warren, Graham W. , Sloan, Jeff A. ... - - Cancer - 2016

Manuscript - No-Endpoint - Meta-Analysis - Prevention - Comprehensive

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials

Regan, Meredith M. , Pagani, Olivia , Fleming, Gini F. ... - - Breast - 2013

Manuscript - No-Endpoint - Trial-Description-Only - Breast - IBCSG-24-02 (SOFT-TEXT)

Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues

Rimm, David L. , Nielsen, Torsten O. , Jewell, Scott D. ... - - J Clin Oncol - 2011

Manuscript - No-Endpoint - Comprehensive - Pathology - C9741 , CALGB-9840

Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - AFT-16

Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia

Ruppert, A S , Yin, J , Davidian, M , Tsiatis, A A , Byrd, J C ... - - Ann. Oncol - 2019

Manuscript - No-Endpoint - Other - Leukemia - A041202

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

Sargent, Daniel J , Patiyil, Smitha , Yothers, Greg ... - - J. Clin. Oncol. - 2007

Manuscript - No-Endpoint - Other - GI - ACCENT

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

Singh, Jasvinder A , Satele, Daniel , Pattabasavaiah, Suneetha ... - - Health Qual Life Outcomes - 2014

Manuscript - No-Endpoint - Meta-Analysis - Health Outcome - NCCTG-95-20-53 , 954651 , 959204 , NCCTG-95-24-52 , NCCTG-964251 , 979202 , NCCTG-97-24-51 , NCCTG-98-24-52 , NCCTG-98-72-51 , NCCTG-959257 , NCCTG-98-72-52 , NCCTG-989251 , NCCTG-969256 , NCCTG-971151 , NCCTG-979251 , NCCTG-979253

Randomized Trial of FOLFOX Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability (ATOMIC, Alliance A021502)

Sinicrope, FA , Ou, F-S , Shi, Q , Nixon, A , Kabir Mody ... - ASCO - J. Clin. Oncol. - 2017

Abstract - No-Endpoint - Trial-Description-Only - GI - A021502

Lessons from Large Scale Collection of Patient Reported Outcomes: Implications for Big Data Aggregation and Analytics

Sloan, Jeff A. , Halyard, Michele , El Naqa, Issam ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2016

Manuscript - No-Endpoint - Other - Health Outcome - N9741 , NCCTG-89-20-52

The ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2− invasive breast cancer

Suman, Vera Jean , Ellis, Matthew J. ... - - Chin Clin Oncol - 2015

Manuscript - No-Endpoint - Trial-Description-Only - Breast - A011106

A phase I/randomized phase II study of MLN0128 vs. Pazopanib in patients with locally advanced/unresectable and/or metastatic sarcoma: Alliance A091304

Tap, William , Mahoney, Michelle , Horvath, Elise ... - ASCO - J. Clin. Oncol. - 2016

Abstract - No-Endpoint - Trial-Description-Only - Experimental - A091304

Alliance A041701 - A randomized phase 2/3 study of conventional chemotherapy +/- uproleselan (GMI-1271) in older adults with acute myeloid leukemia receiving intensive induction chemotherapy

Uy, Geoffrey L. , Yin, Vivien , Klepin, Heidi , Dinner, Shira ... - ASH - Blood - 2019

Abstract - No-Endpoint - Trial-Description-Only - Leukemia - A041701

A randomized phase II trial of vitamin D vs placebo in premenopausal women: CALGB 70806

Wood, M. E. , Kinglsey, F. , Ambaye, A. B. , Yee, L. , Jung, S. J. ... - AACR - Cancer Res. - 2011

Abstract - No-Endpoint - Trial-Description-Only - Prevention - CALGB-70806

Change in mammographic density with metformin use: A companion study to NCIC study MA.32.

Wood, Marie E. , Qin, Rui , Le-Petross, Huong T. , Hwang, E Shelley ... - ASCO - J. Clin. Oncol. - 2013

Abstract - No-Endpoint - Trial-Description-Only - Breast - A211201

Objective Measures of Performance Status in Cancer: A pilot Alliance study

Wood, WA , Tan, X , Grover, NS , Stover, A , Kannappan, A ... - ASCO QCS - J Clin Oncol - 2018

Abstract - No-Endpoint - Primary - Disparities - Pilot

Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial

Woodard, Terri Lynn , Hoffman, Aubri S , Crocker, Laura C ... - - BMJ Open - 2018

Manuscript - No-Endpoint - Trial-Description-Only - ACS CCDRC - NCT03141437

Alliance A041702: A randomized phase III study of ibrutinib plus obinutuzumab versus ibrutinib plus venetoclax and obinutuzumab in untreated older patients (≥ 70 years of age) with chronic lymphocytic leukemia (CLL)

Woyach, Jennifer A. , Ruppert, Amy S. , Perez, Gabriela ... - ASH - Blood. - 2019

Abstract - No-Endpoint - Trial-Description-Only - Leukemia - A041702

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO - J Clin Oncol - 2019

Abstract - No-Endpoint - Trial-Description-Only - GU - A031704